Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

Publication date: September 2020Source: Value in Health Regional Issues, Volume 22Author(s): Faris El-Dahiyat, Islam Eljilany
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research